207 related articles for article (PubMed ID: 35732904)
1. Chemokines and chemokine receptors in allergic rhinitis: from mediators to potential therapeutic targets.
Li Z; Yu S; Jiang Y; Fu Y
Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5089-5095. PubMed ID: 35732904
[TBL] [Abstract][Full Text] [Related]
2. Desloratadine citrate disodium injection, a potent histamine H(1) receptor antagonist, inhibits chemokine production in ovalbumin-induced allergic rhinitis guinea pig model and histamine-induced human nasal epithelial cells via inhibiting the ERK1/2 and NF-kappa B signal cascades.
Chen M; Xu S; Zhou P; He G; Jie Q; Wu Y
Eur J Pharmacol; 2015 Nov; 767():98-107. PubMed ID: 26455479
[TBL] [Abstract][Full Text] [Related]
3. Intranasal steroids in the treatment of allergy-induced rhinorrhea.
Nathan RA
Clin Rev Allergy Immunol; 2011 Aug; 41(1):89-101. PubMed ID: 20514529
[TBL] [Abstract][Full Text] [Related]
4. The Immuno-Modulatory Activities of Pentaherbs Formula on Ovalbumin-Induced Allergic Rhinitis Mice via the Activation of Th1 and Treg Cells and Inhibition of Th2 and Th17 Cells.
Li P; Tsang MS; Kan LL; Hou T; Hon SS; Chan BC; Chu IM; Lam CW; Leung PC; Wong CK
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011470
[TBL] [Abstract][Full Text] [Related]
5. The effect of H1 antagonists carebastine and olopatadine on histamine induced expression of CC chemokines in cultured human nasal epithelial cells.
Yamauchi Y; Fujikura T; Shimosawa T
Allergol Int; 2007 Jun; 56(2):171-7. PubMed ID: 17460445
[TBL] [Abstract][Full Text] [Related]
6. Clinical practice guideline: Allergic rhinitis.
Seidman MD; Gurgel RK; Lin SY; Schwartz SR; Baroody FM; Bonner JR; Dawson DE; Dykewicz MS; Hackell JM; Han JK; Ishman SL; Krouse HJ; Malekzadeh S; Mims JW; Omole FS; Reddy WD; Wallace DV; Walsh SA; Warren BE; Wilson MN; Nnacheta LC;
Otolaryngol Head Neck Surg; 2015 Feb; 152(1 Suppl):S1-43. PubMed ID: 25644617
[TBL] [Abstract][Full Text] [Related]
7. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
Weido AJ; Reece LM; Alam R; Cook CK; Sim TC
Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780
[TBL] [Abstract][Full Text] [Related]
8. [Experiment of genes expression of chemokines and their receptors in allergic rhinitis with gene chip].
Yu S; Zhang R; Liu G; Wen W; Shen X
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jan; 19(2):52-4. PubMed ID: 15844573
[TBL] [Abstract][Full Text] [Related]
9. Gallic acid alleviates nasal inflammation via activation of Th1 and inhibition of Th2 and Th17 in a mouse model of allergic rhinitis.
Fan Y; Piao CH; Hyeon E; Jung SY; Eom JE; Shin HS; Song CH; Chai OH
Int Immunopharmacol; 2019 May; 70():512-519. PubMed ID: 30884431
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine-mediated prevention of inflammatory monocytes infiltration ameliorate ovalbumin-induced allergic rhinitis in mouse model.
Gu X; Xiao F; Lu W; Xu Y; Li X; Yu C; Cui X
Autoimmunity; 2020 Jun; 53(4):218-224. PubMed ID: 32285703
[TBL] [Abstract][Full Text] [Related]
11. Upregulated CCL28 expression in the nasal mucosa in experimental allergic rhinitis: Implication for CD4(+) memory T cell recruitment.
Nagakubo D; Yoshie O; Hirata T
Cell Immunol; 2016 Apr; 302():58-62. PubMed ID: 26868716
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-345-5p acts as an anti-inflammatory regulator in experimental allergic rhinitis via the TLR4/NF-κB pathway.
Liu J; Jiang Y; Han M; Jiang L; Liang D; Li S; Xu Z; Wang L; Li N
Int Immunopharmacol; 2020 Sep; 86():106522. PubMed ID: 32585604
[TBL] [Abstract][Full Text] [Related]
13. Ameliorative effect of selective NLRP3 inflammasome inhibitor MCC950 in an ovalbumin-induced allergic rhinitis murine model.
Zhang W; Ba G; Tang R; Li M; Lin H
Int Immunopharmacol; 2020 Jun; 83():106394. PubMed ID: 32193102
[TBL] [Abstract][Full Text] [Related]
14. Mode of action of intranasal corticosteroids.
Mygind N; Nielsen LP; Hoffmann HJ; Shukla A; Blumberga G; Dahl R; Jacobi H
J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S16-25. PubMed ID: 11449202
[TBL] [Abstract][Full Text] [Related]
15. [Recent advances in allergic rhinitis].
Liang M; Xu R; Xu G
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Feb; 29(3):202-6. PubMed ID: 26012287
[TBL] [Abstract][Full Text] [Related]
16. DMBT1 has a protective effect on allergic rhinitis.
Zhao Y; Tao Q; Wu J; Liu H
Biomed Pharmacother; 2020 Jan; 121():109675. PubMed ID: 31810134
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 1: Pathophysiology, molecular basis].
Klimek L; Högger P; Pfaar O
HNO; 2012 Jul; 60(7):611-7. PubMed ID: 22532281
[TBL] [Abstract][Full Text] [Related]
18. Potential synergistic effects of novel hematopoietic prostaglandin D synthase inhibitor TAS-205 and different types of anti-allergic medicine on nasal obstruction in a Guinea pig model of experimental allergic rhinitis.
Aoyagi H; Kajiwara D; Tsunekuni K; Tanaka K; Miyoshi K; Hirasawa N
Eur J Pharmacol; 2020 May; 875():173030. PubMed ID: 32084417
[TBL] [Abstract][Full Text] [Related]
19. Secretome from bone marrow mesenchymal stem cells: A promising, cell-free therapy for allergic rhinitis.
Zou W; Liu G; Zhang J
Med Hypotheses; 2018 Dec; 121():124-126. PubMed ID: 30396464
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of the aryl hydrocarbon receptor in allergic nasal mucosa, contributing to chemokine secretion in nasal epithelium.
Kim HK; Kook JH; Kang KR; Oh DJ; Kim TH; Lee SH
Am J Rhinol Allergy; 2016 Jul; 30(4):107-12. PubMed ID: 27456584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
